The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Gastric Cancer

Gastric Adenocarcinoma — Diagnosis, Staging, and Multimodal Therapy

Written by: Saygı Hospital Health Guide Editorial Board
Published:

This content is for general information; please consult your physician for diagnosis and treatment.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Gastric Cancer?

Gastric cancer is predominantly adenocarcinoma arising from gastric mucosa, subdivided into intestinal (Lauren) and diffuse types.

H. pylori chronic infection causes 70–80% of non-cardia gastric cancers; gastric cardia tumors relate more to GERD and obesity.

Early diagnosis is critical — survival drops sharply once lymph nodes involved; screening programs are cost-effective in high-incidence regions (Japan, Korea).

Biomarkers: HER2, MSI, PD-L1, and Claudin 18.2 guide targeted and immunotherapy.

Symptoms

Dyspepsia, epigastric pain, and early satiety
Unintentional weight loss and anorexia
Nausea, vomiting, and dysphagia (cardia or pyloric tumors)
Iron-deficiency anemia and melena from occult bleeding
Virchow node (left supraclavicular), Sister Mary Joseph nodule (umbilical), Krukenberg tumor (ovarian metastasis)
Paraneoplastic: acanthosis nigricans, Leser-Trélat sign, migratory thrombophlebitis

Risk Factors

Helicobacter pylori infection and chronic atrophic gastritis
High-salt, smoked, pickled, or nitrate-rich diet; low fruit/vegetable intake
Tobacco smoking and heavy alcohol
Family history and hereditary syndromes (CDH1, Lynch, Li-Fraumeni, FAP)
Pernicious anemia and partial gastrectomy
Male sex, age over 50, and blood group A

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Dyspepsia over age 50 or with alarm features (bleeding, weight loss, dysphagia, anemia)
  • Persistent vomiting, early satiety, or new onset iron-deficiency anemia
  • Family history of gastric cancer or hereditary diffuse gastric cancer syndrome

Treatment Methods

01
Upper endoscopy with multiple biopsies; staging with CT chest/abdomen/pelvis, endoscopic ultrasound, and diagnostic laparoscopy
02
Early gastric cancer (T1a): endoscopic submucosal dissection (ESD) in selected lesions
03
Resectable disease: perioperative FLOT chemotherapy plus gastrectomy (subtotal or total) with D2 lymphadenectomy
04
HER2-positive advanced: trastuzumab plus chemotherapy; Claudin 18.2 positive: zolbetuximab
05
Immunotherapy (nivolumab, pembrolizumab) for PD-L1 positive or MSI-high advanced tumors
06
H. pylori eradication for prevention; endoscopic surveillance for high-risk mucosal lesions and family history

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.